MX2012006276A - Metodo de tratamiento de desordenes del snc. - Google Patents

Metodo de tratamiento de desordenes del snc.

Info

Publication number
MX2012006276A
MX2012006276A MX2012006276A MX2012006276A MX2012006276A MX 2012006276 A MX2012006276 A MX 2012006276A MX 2012006276 A MX2012006276 A MX 2012006276A MX 2012006276 A MX2012006276 A MX 2012006276A MX 2012006276 A MX2012006276 A MX 2012006276A
Authority
MX
Mexico
Prior art keywords
sensing element
treatment
cns disorders
noradrenergic
serotonergic
Prior art date
Application number
MX2012006276A
Other languages
English (en)
Inventor
Christopher D Breder
Original Assignee
Supernus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supernus Pharmaceuticals Inc filed Critical Supernus Pharmaceuticals Inc
Publication of MX2012006276A publication Critical patent/MX2012006276A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La invención comprende un método de tratamiento de desórdenes del SNC mediante un agente farmacéutico que exhibe actividad combinada agonística µ-opioide e inhibidora del transportador de re-admisión noradrenérgico, serotoninérgico o dopaminérgico.
MX2012006276A 2009-12-02 2010-12-02 Metodo de tratamiento de desordenes del snc. MX2012006276A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28201109P 2009-12-02 2009-12-02
PCT/US2010/058745 WO2011068977A1 (en) 2009-12-02 2010-12-02 Method of treatment of cns disorders

Publications (1)

Publication Number Publication Date
MX2012006276A true MX2012006276A (es) 2012-07-10

Family

ID=44115290

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012006276A MX2012006276A (es) 2009-12-02 2010-12-02 Metodo de tratamiento de desordenes del snc.

Country Status (6)

Country Link
US (4) US20120302615A1 (es)
EP (1) EP2506715A4 (es)
AU (1) AU2010326016B2 (es)
CA (1) CA2782314C (es)
MX (1) MX2012006276A (es)
WO (1) WO2011068977A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931217A (en) * 1967-03-30 1976-01-06 Hoffmann-La Roche Inc. 2,3-Dihydro-5-alkoxy-5-phenyl-5H-imidazo[2,1-a]isoindoles
US5447948A (en) * 1992-05-07 1995-09-05 Yale University Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia
US20030180352A1 (en) 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU2002243451A1 (en) * 2001-01-02 2002-07-16 Sention, Inc. Use of catecholamine reuptake inhibitors to enhance memory
FR2899476B1 (fr) * 2006-04-11 2008-07-04 Assist Publ Hopitaux De Paris Association du mazindol dans le traitement du deficit de l'attention/hyperactivite
US20090318520A1 (en) * 2008-06-20 2009-12-24 Afecta Pharmaceuticals Drive Use of isoindoles for the treatment of neurobehavioral disorders

Also Published As

Publication number Publication date
AU2010326016A1 (en) 2012-06-14
US20230355589A1 (en) 2023-11-09
WO2011068977A1 (en) 2011-06-09
CA2782314C (en) 2019-03-26
EP2506715A1 (en) 2012-10-10
US20160136135A1 (en) 2016-05-19
CA2782314A1 (en) 2011-06-09
US11911368B2 (en) 2024-02-27
US20120302615A1 (en) 2012-11-29
AU2010326016B2 (en) 2015-04-02
US20200069653A1 (en) 2020-03-05
EP2506715A4 (en) 2013-05-15

Similar Documents

Publication Publication Date Title
MX2012006325A (es) Sensor de gas con compensacion para variaciones de linea base.
EP3448254B1 (en) A method for collecting a selective portion of a subject's breath
JP6861270B2 (ja) 呼気サンプルを捕捉するためのシステムおよびデバイス
Güder et al. Paper‐based electrical respiration sensor
WO2011032132A3 (en) Body-worn monitor for measuring respiration rate
TWI503102B (zh) 隨身可及的醫療診斷、檢查及監測之手持式氣體分析系統
WO2020104465A3 (en) Methods and apparatus for detection of disordered breathing
DE102004042797A1 (de) Erfassungsgerät sowie Verfahren zur Observation schlafbezogener Atmungsstörungen
CN114306839A (zh) 呼吸驱动吸入器的依从性监控模块
WO2007103474A3 (en) Drug adherence monitoring system
MX2014015337A (es) Dispositivo personal de monitoreo de funcion pulmonar capaz de un analisis de aliento exhalado.
WO2013028705A3 (en) Asthma monitoring device
WO2011132118A3 (en) Respiratory motion detection apparatus
MX339200B (es) Sensor de temperatura adaptable para dispositivo de monitoreo de respiración.
WO2007101141A3 (en) A medical signal processing system with distributed wireless sensors
NZ593988A (en) Apparatus and method of diagnosis of Cheyne-Stokes breathing in a person
JP2016531696A5 (es)
WO2020049438A3 (en) System for detection of volatile organic compounds (voc) in exhaled breath for health monitoring
RU2016111654A (ru) Система измерения углекислого газа у новорожденных
GB2488743A (en) Physiological monitoring device and method
HK1137314A1 (en) Detection pain/awakening integral value
US20170071477A1 (en) System for detecting core body temperature and method for the same
WO2012066280A3 (en) Blood analysis apparatus and method
FI20065787A0 (sv) System, mätinstrument och förfarande för att mäta personens elektrokardiogram
KR20160107752A (ko) 사용자 모니터링을 위한 착용형 장치 및 시스템

Legal Events

Date Code Title Description
FC Refusal